Nexviadyme 100 mg powder for concentrate for solution for infusion
GZ-2016-11512
Approved small_molecule active
Quick answer
Nexviadyme 100 mg powder for concentrate for solution for infusion for Glycogen storage disease type II or acid maltase deficiency, Pompe disease is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Glycogen storage disease type II or acid maltase deficiency, Pompe disease
- Phase
- Approved
- Modality
- small_molecule
- Status
- active